Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe.

Engers DW, Frist AY, Lindsley CW, Hong CC, Hopkins CR
Bioorg Med Chem Lett. 2013 23 (11): 3248-52

PMID: 23639540 · PMCID: PMC3677712 · DOI:10.1016/j.bmcl.2013.03.113

MeSH Terms (14)

Activin Receptors, Type I Animals Bone Morphogenetic Protein Receptors Half-Life Heterocyclic Compounds, 2-Ring Humans Mice Protein Binding Protein Isoforms Pyrazoles Pyrimidines Quinolines Rats Structure-Activity Relationship

Connections (5)

This publication is referenced by other Labnodes entities: